Reports
Public research reports
Reports the team explicitly publishes to this site. Each one is a multi-agent research reference with an analysis date and final Portfolio Manager rating. Not investment advice or trade execution.
Final five-tier rating from the Portfolio Manager. Not the intermediate Trader action.
- Hold
Shell Plc
SHEL.LLSEHold Shell Plc (SHEL.L) at 3,539 GBX with an active stop at 3,420 GBX; let LNG Canada Phase 2 FID (early Oct) and Q3 earnings (Oct 29) break the balanced risk/reward tie.
Analysis date2026-09-20
Analysis languageEnglish
Reports1 reports
Open report - Underweight
HSBC Holdings Plc
HSBA.LLSETrim HSBA.L to 50–75% of benchmark into the 1515–1540 shelf; Underweight with a 1456 GBX target, completing the reduction on a daily close below 1488.
Analysis date2026-09-20
Analysis languageEnglish
Reports2 reports
Open report - Hold
Glencore plc
GLEN.LLSEHold GLEN.L at benchmark weight — no add at 556.80, no exit; let price versus 584.47 and 525.94 plus FCF and litigation disclosure decide the next move.
Analysis date2026-09-20
Analysis languageEnglish
Reports1 reports
Open report - Underweight
British American Tobacco p.l.c.
BATS.LLSEUnderweight BATS.L — trim roughly one-third to ~60-65% of benchmark on the broken medium-term trend, keeping a residual for the yield and buyback bid.
Analysis date2026-09-20
Analysis languageEnglish
Reports1 reports
Open report - Underweight
Rolls-Royce Holdings plc
RR..LLSEUnderweight RR..L: trim one-quarter to one-third into the 1468-1489 resistance cluster, keep a sub-half core, and re-add only on a volume-confirmed reclaim above 1489.
Analysis date2026-09-20
Analysis languageEnglish
Reports1 reports
Open report - Overweight
Barclays PLC
BARC.LLSEOverweight BARC.L — stage a gradual build at 455–462 GBX, adding on a 200 SMA reclaim (466.81–467.06) with risk defined at ~450 GBX.
Analysis date2026-09-20
Analysis languageEnglish
Reports1 reports
Open report - Buy
Meta Platforms Inc Class A
METANASDAQPrice Target: $790.00** (12-month horizon, in USD)
Analysis date2026-09-09
Analysis languageEnglish
Reports4 reports
Open report - Underweight
Cerebras Systems, Inc. Class A
CBRSNASDAQReduce CBRS to approximately 40% of normal position size by selling into the $216–$217 resistance zone; hold a hard stop at $190 and await Q3 margin recovery, a confirmed 200-day SMA breakout, or an end to insider selling before re-entering.
Analysis date2026-09-06
Analysis languageEnglish
Reports1 reports
Open report - Hold
Coca-Cola Company
KONYSEHold current position with tighter $85.00 stop-loss and wait for $92.00+ breakout with momentum confirmation before reassessing exposure.
Analysis date2026-09-02
Analysis languageEnglish
Reports1 reports
Open report - Hold
Wells Fargo & Company
WFCNYSEHold current position in Wells Fargo & Company (WFC) pending confirmation at key technical levels.
Analysis date2026-09-02
Analysis languageEnglish
Reports1 reports
Open report - Hold
Salesforce, Inc.
CRMNYSEHold current position with disciplined risk management: tighten stop to $268 and take partial profits at $260–$265.
Analysis date2026-09-02
Analysis languageEnglish
Reports1 reports
Open report - Hold
Credo Technology Group Holding Ltd.
CRDONASDAQHold current position; await confirmation of FCF sustainability or technical trend reversal before adjusting exposure.
Analysis date2026-09-02
Analysis languageEnglish
Reports1 reports
Open report - Hold
Advanced Micro Devices, Inc.
AMDNASDAQHold current position in AMD, respecting near-term technical headwinds while maintaining exposure to its long-term AI infrastructure leadership.
Analysis date2026-09-02
Analysis languageEnglish
Reports2 reports
Open report - Hold
Interlink Electronics, Inc.
LINKNASDAQHold current position with dynamic risk management: add on pullbacks to $5.16 or $5.01, take partial profits at $5.89, and enforce stop-loss at $4.68.
Analysis date2026-09-01
Analysis languageEnglish
Reports1 reports
Open report - Sell
WF Holding Limited
WFFNASDAQSell WFF immediately: accelerating cash burn, confirmed bearish momentum, and zero catalysts invalidate any long thesis.
Analysis date2026-09-01
Analysis languageEnglish
Reports1 reports
Open report - Sell
Valion Bio, Inc.
VBIONASDAQSell immediately: VBIO faces imminent financial exhaustion with no near-term catalyst to reverse its terminal decline.
Analysis date2026-09-01
Analysis languageEnglish
Reports1 reports
Open report - Hold
Evolution Metals & Technologies Corp.
EMATNASDAQHold with zero exposure pending Q3 earnings confirmation of commercial traction.
Analysis date2026-09-01
Analysis languageEnglish
Reports1 reports
Open report - Underweight
System1, Inc. Class A
SSTNYSEReduce existing exposure to minimal or zero position by end of Q3 2026; do not add under any circumstance.
Analysis date2026-09-01
Analysis languageEnglish
Reports1 reports
Open report
Report library guide
How to use these AI equity research reports
Which reports appear in this public library?
Only completed reports that the TradingAgents Report team explicitly publishes to this site appear here. Each card identifies the listing, exchange, analysis date, output language, and final Portfolio Manager rating.
Does a Portfolio Manager rating tell me what to buy or sell?
No. The rating is the final research assessment for that report's analysis date. It is not personalized investment advice, a brokerage instruction, or an automated trade.
What should I check before relying on a report?
Start with the analysis date and the report's evidence, debate, risk review, and invalidation conditions. Verify current market information independently because prices, filings, and news can change after publication.
For context, review the research method and the market-data and date-boundary guide.